Европейский союз - английский - EMA (European Medicines Agency)

ratiopharm gmbh - sildenafil - erectile dysfunction - urologicals - treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for sildenafil to be effective, sexual stimulation is required.

Европейский союз - английский - EMA (European Medicines Agency)

teva b.v. - telmisartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension in adults

Европейский союз - английский - EMA (European Medicines Agency)

teva b.v.  - temozolomide - glioma; glioblastoma - antineoplastic agents - for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy (rt) and subsequently as monotherapy treatment.for the treatment of children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.

Европейский союз - английский - EMA (European Medicines Agency)

actavis group ptc ehf   - zoledronic acid monohydrate - fractures, bone - drugs for treatment of bone diseases - prevention of skeletal-related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.treatment of adult patients with tumour-induced hypercalcaemia.

Европейский союз - английский - EMA (European Medicines Agency)

teva b.v. - zoledronic acid - fractures, bone; cancer - drugs for treatment of bone diseases - prevention of skeletal-related events and treatment of tumour-induced hypercalcaemia.

Канада - английский - Health Canada

accel pharma inc - pioglitazone (pioglitazone hydrochloride) - tablet - 15mg - pioglitazone (pioglitazone hydrochloride) 15mg - thiazolidinediones

Канада - английский - Health Canada

accel pharma inc - pioglitazone (pioglitazone hydrochloride) - tablet - 30mg - pioglitazone (pioglitazone hydrochloride) 30mg - thiazolidinediones

Канада - английский - Health Canada

accel pharma inc - pioglitazone (pioglitazone hydrochloride) - tablet - 45mg - pioglitazone (pioglitazone hydrochloride) 45mg - thiazolidinediones

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

transdermal ltd - midodrine hydrochloride - oral tablet - 2.5mg

Европейский союз - английский - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologicals - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv)